Expert Opinion on Emerging Drugs

Aims & Scope

Expert Opinion on Emerging Drugs (ISSN 1472-8214 [print], 1744-7623 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing structured reviews on Phase II and Phase III drugs/drug classes emerging onto the market across all therapy areas, providing expert opinion on their potential impact on the current management of specific diseases.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	2.7
2024	2.70

SJR (SCImago Journal Rank)

Year	Value
2024	1.034

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	58

Journal Rank

Year	Value
2024	4561

Journal Citation Indicator

Year	Value
2024	224

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Emerging PEGylated drugs

  Citation: 221

  Authors: Jung Seok, Patrick P, Kang Choon

• What is the future of PEGylated therapies?

  Citation: 216

  Authors: Magdalena, Kang Choon, Seulki

• Emerging treatments for traumatic brain injury

  Citation: 188

  Authors: Ye, Asim, Michael

• Carbonic anhydrase inhibitors as emerging drugs for the treatment of obesity

  Citation: 155

  Authors: Claudiu T, Anna Di, Giuseppina De

• Cannabinoid receptor antagonists: pharmacological opportunities, clinical experience, and translational prognosis

  Citation: 154

  Authors: David R, Alexandros

• Emerging treatments for noise-induced hearing loss

  Citation: 154

  Authors: Naoki, Jochen

• Transgenic plants in the biopharmaceutical market

  Citation: 154

  Authors: Richard M, Stefan, Rainer

• Disease-modifying drugs in osteoarthritis: current understanding and future therapeutics

  Citation: 142

  Authors: Win Min, Shirley Pei-Chun, Matthew Sean, David John

• Emerging anti-HIV drugs

  Citation: 135

  Authors: Erik

• Liposomal amphotericin B as a treatment for human leishmaniasis

  Citation: 121

  Authors: Manica, Koert, Maria Angeles, Sakib, Gemma, Barbara, Sara, Julien, François

---